{"id":"5ab74356-4463-4275-ae5d-f4de09f95bf4","arxiv_id":"2501.00954","paper_version":1,"verdict":"REJECT","confidence":"MODERATE","novelty_score":4.0,"correctness_risk":"medium","formal_verification":"none","parameter_count":0,"one_line_summary":"A StyleGAN3 model generates realistic synthetic DR1 fundus images with good FID/KID scores, but the paper does not test whether these images improve any diabetic retinopathy classifier.","lead":"This paper trains a StyleGAN3 model on 2,602 real DR1 diabetic retinopathy fundus images and reports a final FID of 17.29 for the generated images. The stated goal is to use these synthetic images to improve early detection models, but no classifier is trained or evaluated in the paper.","discovery_kind":"extension","skeptic_critique":{"model":"deepseek-v4-flash","headline":"Untested downstream benefit: no classifier augmentation experiment supports the claim that synthetic DR1 images improve early DR detection, so FID/KID/Turing results cannot carry the conclusion.","rationale":"I read the paper in good faith as an application of StyleGAN3 to a scarce medical image class. The generative setup is plausible, and the image-quality metrics, while limited, are not inherently implausible. However, the paper's central promise is explicitly about augmenting supervised classifiers to improve early DR detection, and that promise is never tested. Every claimed benefit in the Abstract, Section 4.1, and the Conclusion is phrased as enabling or improving classifier training, but no classifier is trained or evaluated. The reported metrics establish a certain degree of distributional similarity between real and synthetic images; they do not establish that the synthetic images carry the diagnostic signal needed for detection, nor that augmenting with them helps rather than hurts. The reader's weakest_assumption identifies exactly this gap, and I agree with that identification. The FID significance argument is an additional weakness, but the missing augmentation study is the load-bearing issue because it is the only direct support for the headline claim. I would not accuse the authors of dishonesty; the generative result may well be useful, but the paper as written does not support its central conclusion. Therefore I recommend no change to the reader's REJECT verdict. A concrete downstream classifier experiment, as described in the test field, would be the decisive check and, if successful, would support a revised, more limited claim about augmentation utility.","tokens_in":8162,"tokens_out":2544,"duration_ms":25090,"concrete_test":"Train a DR1-versus-normal classifier (e.g., ResNet-50) under three conditions: (a) real DR1 images only, (b) real plus 5,000 synthetic images, and (c) real plus 10,000 synthetic images, using the same held-out real test set (for example, Messidor/Kaggle splits) for all conditions. If augmentation does not improve AUROC or PR-AUC over real-only training by a pre-specified margin, or at least match it within confidence intervals, then the conclusion that the synthetic images are sufficient for augmenting training datasets is unsupported. A synthetic-only training run should also be reported to check whether label-relevant microaneurysm features are actually learned.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claim, stated in the Abstract, §1, §4.1, and the Conclusion, is that StyleGAN3-generated DR1 images are 'sufficient for augmenting training datasets and improving early detection of Diabetic Retinopathy.' For this claim to hold, synthetic images must improve a supervised DR1 classifier trained on them. The paper provides no classifier experiment: there is no augmented-vs-real training comparison, no held-out real test set, and no detection metric. The reported FID (17.29), KID (0.018), equivariance scores, spectral overlap, and Turing-test misclassification (540 of 600 synthetic images called real) are image-quality correlates, not downstream task evidence. FID and KID can be low while synthetic data fails to help a classifier, for example if generated images lack label-relevant microaneurysm cues or systematically encode border artifacts that a classifier latches onto. The paper's own limitation section (§4.4) identifies dataset size and edge artifacts but not this missing validation, which is the actual load-bearing gap. Additionally, the claimed statistical significance of the FID score is weak: the final 17.29 is a selected checkpoint compared against a bootstrap distribution of training-time FID scores; selection makes a below-interval score expected, so it does not establish that the final model is genuinely better. The untested causal chain from image realism to classifier improvement is the core unsupported step.","agreement_with_reader":"agree"},"referee_report":{"model":"deepseek-v4-flash","summary":"The paper trains a StyleGAN3 model on 2,602 DR1 fundus images and evaluates the generated synthetic images using FID, KID, equivariance metrics, spectral analysis, and a human Turing test with six ophthalmologists. The authors report a final FID of 17.29, a KID of 0.018, and that 540 of 600 synthetic images were misclassified as real by the ophthalmologists. On this basis, the abstract and conclusion claim that these synthetic images are 'sufficient for augmenting training datasets and improving early detection of Diabetic Retinopathy.' The manuscript does not train or evaluate a supervised classifier with augmented data, and the statistical test used to claim significance of the FID score compares a selected minimum against a bootstrap distribution of training-time scores.","tokens_in":8378,"tokens_out":3732,"duration_ms":34459,"significance":"If the central claim were established, the result would be of practical interest: synthetic DR1 images that reliably augment small clinical datasets could help improve automated early DR screening. The paper has some useful ingredients: it uses a modern generative architecture, reports a plausible set of image-quality metrics, includes a human evaluation, and describes the training configuration in detail. However, the stated contribution is explicitly about improving supervised classifiers, and no classifier experiment is performed. The reported metrics are all correlates of image realism, not evidence of downstream task benefit. The statistical treatment of the headline FID result is also flawed. These are load-bearing gaps, not presentation issues.","major_comments":[{"comment":"The central claim, repeated in the Abstract, §1, §4.1, and the Conclusion, is that StyleGAN3-generated DR1 images are 'sufficient for augmenting training datasets and improving early detection of Diabetic Retinopathy.' The manuscript contains no experiment that trains or evaluates a supervised classifier with synthetic DR1 images, let alone a comparison against training on real images only. All reported evidence (FID, KID, equivariance, spectral overlap, and the Turing test) concerns image realism, not detection performance. A generative model can have excellent FID/KID values while its samples fail to improve a classifier, for example if the synthetic images encode border artifacts or miss the subtle microaneurysm cues that are label-relevant. The untested causal chain from image realism to classifier improvement is the load-bearing assumption of the paper, and it must be tested (e.g., an augmented-vs-real training comparison on a held-out set of real DR1 images) before the stated conclusion can be drawn. As written, the conclusion overstates what the evidence supports.","section":"§3.4, §3.1.1"},{"comment":"The claimed statistical significance of the final FID of 17.29 is not valid. The number 17.29 is a single value selected from the training process (apparently the best or final checkpoint), and it is compared against a bootstrap distribution constructed from the last 30% of training epochs, with a reported mean of 21.18 and 95% CI 20.83–21.56. Because the final value is selected from the same training curve, it is expected to be below the lower bound of the bootstrap distribution of earlier values; this is a minimum-vs-distribution comparison, not a test of whether the final model is genuinely better than the training distribution. The validity of the bootstrap CI is further undermined by the authors' own Shapiro-Wilk result (statistic 0.87, CI 0.79–0.94), which indicates non-normality of the FID scores, so the normal-based CI is not interpretable in the standard way. The Mann-Whitney U test compares FID scores from initial and later training stages, which does not support the claim about the final checkpoint. Please report the full FID trajectory, use a proper selection-bias correction, or evaluate FID on a held-out real-image set that was not used for training.","section":"§3.2.1, Table 2"},{"comment":"The interpretation of the Human Turing Test results is overstated. The chi-square test (statistic 666.67, p = 5.2e-147) shows that the six ophthalmologists could distinguish real from synthetic images at a level far better than chance, yet the paper concludes that the synthetic images possess 'a high degree of realism' because 540 of 600 synthetic images were incorrectly identified as real. That 90% false-positive rate for synthetic images is one useful descriptive statistic, but it does not, by itself, support the conclusion that the images can augment classifier training. Moreover, the table shows that real images were also misclassified (63/600), so a more informative analysis would report sensitivity and specificity for real and synthetic conditions. The claim that these results 'validate the utility of synthetic data as a reliable substitute for real data in training supervised classifiers' is a downstream claim that cannot be derived from a perceptual Turing test alone.","section":"§3.3"},{"comment":"The spectral analysis section is presented as supporting the 'diagnostic utility' of the synthetic images, but it is entirely qualitative. The text reports that FFT amplitude spectra and average power spectrum heatmaps 'revealed similarities in the central regions' and 'discrepancies were observed near the boundaries,' but no quantitative measure (e.g., mean squared error between spectra, correlation coefficient, or a normalized distance) is provided. Consequently, the conclusion that the mismatches 'did not affect the overall diagnostic utility' is unsupported. In addition, the section contains two consecutive subsections both titled '3.3.1 Approach' and '3.3.2 Approach,' which suggests a structural error in the manuscript.","section":"§3.3"}],"minor_comments":[{"comment":"The KID score is reported as a single point estimate (0.018) without a confidence interval or bootstrap variance; KID is typically reported with a confidence interval because it is computed on a finite sample.","section":"§2"},{"comment":"The training configuration in Table 1 lists a 'Channel Base' of 32,768 with a 'Channel Max' of 512. This value is surprising and likely a typo, since the standard StyleGAN3 configuration for a 512-pixel resolution uses a channel base of 32768? Please verify and correct the number, and confirm that the reported configuration is the one used in the experiments.","section":"§2"},{"comment":"The comparison 'Compared to similar studies in medical image synthesis, where FID scores typically range from 20–30' is made without citations or a systematic comparison; please either provide a proper reference or remove the unsupported benchmark statement.","section":"§3.1.1"},{"comment":"The equivariance metrics EQ-T and EQ-R are reported as 65.65 and 64.64 in §3.1.2, but the methods section refers to PSNR in decibels as the basis for equivariance evaluation. Please state explicitly what these numbers measure and include units or a reference to the exact formula.","section":"§3.1.2"},{"comment":"Several references are incomplete or have irregular formatting, for example Ref. 2 (missing volume/page numbers) and Ref. 17 (missing full citation details). Please unify the reference style.","section":"References"}],"recommendation":"reject","confidential_remarks":"The paper's central claim is explicitly about improving supervised DR1 detection, yet no classifier experiment is reported. The FID significance test is structurally flawed because it compares a selected minimum against a bootstrap distribution of training-time scores. The authors would need to add a substantial downstream validation study (e.g., training a DR1 classifier with and without synthetic augmentation and evaluating on a held-out real set) and correct the statistical analysis to make the paper support its conclusions. Within the current manuscript scope, these are load-bearing gaps, not minor revisions. I recommend rejection."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"This is a straightforward StyleGAN3 application to a small DR1 fundus dataset. As far as generation goes, the work looks credible: the training recipe is described in unusual detail, and the reported FID (17.29), KID (0.018), and equivariance scores are plausible for this kind of medical data. But the paper's stated purpose—synthetic DR1 images that improve early DR detection—is never tested. There is no classifier experiment anywhere.\n\nWhat is actually new is modest. StyleGAN3 is a published architecture; training it on a curated DR1 set from Messidor, Kaggle, and a proprietary camera is a standard application in the GAN-for-medical-imaging literature. The evaluation is broader than many such papers, with spectral analysis and a six-ophthalmologist Turing test, and the authors are open about the small dataset and edge artifacts. Those parts are honest and potentially useful as a baseline.\n\nThe soft spot is load-bearing. The conclusion that these images are 'sufficient for augmenting training datasets and improving early detection' never gets tested. You would need an augmentation study: train a DR1 classifier on real plus synthetic versus real only, evaluate on a held-out real test set, and show a gain. The paper has no such experiment. Image-quality metrics cannot carry this claim. Low FID and KID do not guarantee that the synthetic images preserve label-relevant microaneurysm cues or that a classifier will not latch onto border artifacts. The paper's own limitation section (§4.4) lists dataset size and edge artifacts but not this missing validation, which is the actual gap.\n\nThe statistical significance argument for the final FID is also weak. The achieved 17.29 is a single selected checkpoint compared against a bootstrap distribution of FID scores from the last 30% of training epochs. Selection alone makes a below-interval score likely, so this does not establish that the final model is genuinely better than typical training checkpoints. I would treat that FID as descriptive, not as a test result.\n\nOne more issue: the Turing test actually showed that the ophthalmologists distinguished real from synthetic significantly better than chance (chi-square p ≈ 1e-147). The paper highlights the 540 of 600 synthetic images misclassified as real, which is fine, but the overall result is that experts can tell them apart, mostly from edge artifacts. That is not a passing Turing test, and the framing should acknowledge that more squarely.\n\nWho is this for? Researchers who want a worked StyleGAN3 training recipe on fundus images and some descriptive quality metrics will find it useful. Anyone who wants evidence that synthetic DR1 data improves early DR detection will not find it here. The underlying work is real and the missing experiment is fixable, so it deserves a serious referee; but as submitted, the central claim is unsupported.","headline":"A competent StyleGAN3 application undermined by a missing classifier experiment; the central augmentation claim rests on image-quality metrics that don't bear it.","tokens_in":8928,"tokens_out":2775,"would_cite":false,"duration_ms":24045,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"The paper claims that StyleGAN3 can generate synthetic DR1 fundus images that closely match real images, and that these synthetic images are sufficient for augmenting training datasets to improve early diabetic retinopathy detection.","keywords":["Diabetic Retinopathy","DR1","StyleGAN3","synthetic image generation","fundus photography","microaneurysms","FID","data augmentation"],"falsifier":"Train a DR1 classifier on a fixed number of real DR1 images, then add the synthetic DR1 images to the training set and evaluate sensitivity and specificity on a held-out real test set; if adding synthetic data does not improve (or degrades) performance relative to training on real images alone, the claim that these images are sufficient for augmentation would be falsified.","tokens_in":7926,"feed_emoji":"👁","tokens_out":3905,"duration_ms":34286,"temperature":0.7,"pith_summary":"The paper argues that StyleGAN3, trained on 2,602 real DR1 fundus images, can generate synthetic images with microaneurysms that are visually and statistically close to real ones. Evidence includes an FID of 17.29, a KID of 0.018, and a Turing test in which ophthalmologists misclassified 540 of 600 synthetic images as real. The authors propose that these synthetic images can augment scarce training datasets, helping supervised classifiers detect early diabetic retinopathy and potentially reducing preventable blindness. Notably, the paper does not train or evaluate a classifier, so the direct benefit for detection remains an inference from image-quality metrics.","feed_headline":"Synthetic retina images pass as real in expert test","feed_subtitle":"StyleGAN3 trained on 2,602 DR1 images scores FID 17.29, a step toward easing data scarcity in diabetic retinopathy screening.","key_machinery":"The mechanism is StyleGAN3, an alias-free generative adversarial network designed for translation and rotation equivariance. Its alias-free architecture reduces sampling artifacts and preserves fine textural details such as microaneurysms, while the equivariance properties keep features correctly positioned under geometric transformations. The model is trained from scratch using a custom DR1 fundus dataset with data augmentation, and evaluated with Fréchet Inception Distance (FID), Kernel Inception Distance (KID), equivariance metrics, spectral analysis, and human Turing tests.","core_discovery":"The central discovery is that a StyleGAN3 network trained from scratch on just 2,602 DR1 fundus images can synthesize images that closely match the real data distribution, preserving microaneurysms, the earliest visible sign of diabetic retinopathy. Quantitative evaluation yielded FID 17.29 and KID 0.018, and spectral FFT analysis showed strong similarity in diagnostically important regions. In a Turing test with six ophthalmologists, the synthetic images were mistaken for real in 540 of 600 presentations, even though the experts could distinguish the two sets overall (chi-square 666.67, p ≈ 1e-147). The paper concludes that these synthetic DR1 images are sufficiently realistic and diverse to serve as training data augmentation for improving early detection of diabetic retinopathy.","pith_inferences":["A direct test of the paper's core claim would be to train a DR1 classifier on real images alone versus real plus synthetic images and measure sensitivity/specificity on a held-out real test set; the paper does not report such an experiment, so the improvement is an untested consequence.","The edge artifacts noted in the Turing test and spectral analysis could likely be reduced by training on a larger dataset or using preprocessing, which would probably further increase the fraction of synthetic images mistaken for real.","The bootstrap confidence interval for FID (21.18, 95% CI 20.83–21.56) is compared against a single FID value of 17.29, but FID itself has sampling variability; a more robust validation would compare distributions of FID from multiple real and synthetic cohorts or evaluate downstream task performance.","If the approach is extended to other imaging modalities, the same methodological gap may recur: generative quality metrics do not automatically guarantee clinical utility without task-level evaluation."],"forward_implications":["Synthetic DR1 images can be added to real training sets to increase the number of microaneurysm-positive examples without new annotations, potentially improving supervised classifier performance on early diabetic retinopathy detection.","The same pipeline can be extended to later DR stages (DR2, DR3) and other medical imaging domains where annotated data are scarce, by fine-tuning the StyleGAN3 backbone.","In underserved regions with limited access to annotated fundus images, synthetic data could enable building AI-based screening tools that detect early DR and help prevent blindness.","The low FID/KID scores and the high rate of expert misclassification suggest the synthetic images retain diagnostically relevant features, making them a plausible substitute for real images in classifier training within the study's scope."],"supporting_citations":[{"why":"Defines StyleGAN3, the alias-free GAN architecture that the paper trains from scratch to generate DR1 images.","marker":"[3]"},{"why":"Introduces the Fréchet Inception Distance (FID), the primary quantitative metric used to assess synthetic image fidelity.","marker":"[13]"},{"why":"Introduces the Kernel Inception Distance (KID), the second distribution-similarity metric that complements FID.","marker":"[14]"},{"why":"Provides the Turing test concept, which the paper adapts for human evaluation of synthetic retinal images by ophthalmologists.","marker":"[16]"},{"why":"Motivates the use of synthetic data for augmenting medical image classifiers, framing the paper's goal of improving early DR detection.","marker":"[4]"}],"fun_headline_variants":["Synthetic retina images fool eye doctors 90% of the time","StyleGAN3-synthesized DR1 images beat data scarcity","AI-made retinas pass Turing test with 90% accuracy","Synthetic retinas: 90% fool ophthalmologists"],"cache_read_input_tokens":3200,"weakest_assumption_plain":"The claim that the synthetic images improve early DR detection rests on the untested assumption that low FID, low KID, and expert misclassification of synthetic images translate into better supervised classifier performance on real DR1 images — the paper never trains or evaluates a classifier.","fun_headline_variants_meta":{"raw":{"variants":["Synthetic retina images fool eye doctors 90% of the time","StyleGAN3-synthesized DR1 images beat data scarcity","AI-made retinas pass Turing test with 90% accuracy","Synthetic retinas: 90% fool ophthalmologists"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.001257,"raw_usage":{"total_tokens":5163,"prompt_tokens":973,"completion_tokens":4190,"prompt_tokens_details":{"cached_tokens":384},"prompt_cache_hit_tokens":384,"prompt_cache_miss_tokens":589,"completion_tokens_details":{"reasoning_tokens":4119}},"tokens_in":589,"tokens_out":4190,"duration_ms":25189,"temperature":1.0,"reasoning_tokens":4119,"cache_read_input_tokens":384,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-10T22:38:13.102477+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"Train a DR1 classifier on a fixed number of real DR1 images, then add the synthetic DR1 images to the training set and evaluate sensitivity and specificity on a held-out real test set; if adding synthetic data does not improve (or degrades) performance relative to training on real images alone, the claim that these images are sufficient for augmentation would be falsified.","supporting_citations":[],"review_version":1}